265 related articles for article (PubMed ID: 33630753)
1. THERAPY OF ENDOCRINE DISEASE: Novel protection and treatment strategies for chemotherapy-associated ovarian damage.
Xiong J; Xue L; Li Y; Tang W; Chen D; Zhang J; Dai J; Zhou S; Lu Z; Wu M; Wang S
Eur J Endocrinol; 2021 May; 184(5):R177-R192. PubMed ID: 33630753
[TBL] [Abstract][Full Text] [Related]
2. Ovarian damage from chemotherapy and current approaches to its protection.
Spears N; Lopes F; Stefansdottir A; Rossi V; De Felici M; Anderson RA; Klinger FG
Hum Reprod Update; 2019 Nov; 25(6):673-693. PubMed ID: 31600388
[TBL] [Abstract][Full Text] [Related]
3. Strategies for fertility preservation in young early breast cancer patients.
Tomasi-Cont N; Lambertini M; Hulsbosch S; Peccatori AF; Amant F
Breast; 2014 Oct; 23(5):503-10. PubMed ID: 24934638
[TBL] [Abstract][Full Text] [Related]
4. Advances in the Treatment and Prevention of Chemotherapy-Induced Ovarian Toxicity.
Cho HW; Lee S; Min KJ; Hong JH; Song JY; Lee JK; Lee NW; Kim T
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096794
[TBL] [Abstract][Full Text] [Related]
5. Preservation of gonadal function in women undergoing chemotherapy: a review of the potential role for gonadotropin-releasing hormone agonists.
Hickman LC; Valentine LN; Falcone T
Am J Obstet Gynecol; 2016 Oct; 215(4):415-22. PubMed ID: 27422055
[TBL] [Abstract][Full Text] [Related]
6. Fertility preservation in women with CNS tumors.
Tosoni A; Balestrini D; Brandes AA
Expert Rev Anticancer Ther; 2017 May; 17(5):439-445. PubMed ID: 28395560
[TBL] [Abstract][Full Text] [Related]
7. Preliminary results of a counselling programme for fertility preservation in female cancer patients: The experience of the GEMME DORMIENTI network.
Ciccarone M; Hohaus S; Pulsoni A; Cavaceppi P; Franzò S; Fabbri R; Cudillo L; Battistini R; Di Rocco A; Annibali O; Cox MC; Provenzano I; Abruzzese E; Renzi D; Tesei C; Anticoli Borza P; Cuccaro A; Andriani A; D'Elia GM; Facchiano A; Marchetti P; Cantonetti M
Eur J Cancer Care (Engl); 2020 Jan; 29(1):e13174. PubMed ID: 31571303
[TBL] [Abstract][Full Text] [Related]
8. Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.
Senra JC; Roque M; Talim MCT; Reis FM; Tavares RLC
Ultrasound Obstet Gynecol; 2018 Jan; 51(1):77-86. PubMed ID: 29055060
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Chemotherapy on the Ovaries: Molecular Aspects and the Prevention of Ovarian Damage.
Sonigo C; Beau I; Binart N; Grynberg M
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717833
[TBL] [Abstract][Full Text] [Related]
10. [Fertility preservation strategies in young women in case of breast cancer or hematologic malignancy].
Decanter C; Robin G
Gynecol Obstet Fertil; 2013 Oct; 41(10):597-600. PubMed ID: 24094596
[TBL] [Abstract][Full Text] [Related]
11. When helping hurts: the effect of surgical interventions on ovarian reserve.
Jacob GP; Oraif A; Power S
Hum Fertil (Camb); 2016 Apr; 19(1):3-8. PubMed ID: 26982599
[TBL] [Abstract][Full Text] [Related]
12. Fertility after breast cancer treatment.
Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568
[TBL] [Abstract][Full Text] [Related]
13. Present and future fertility preservation strategies for female cancer patients.
Georgescu ES; Goldberg JM; du Plessis SS; Agarwal A
Obstet Gynecol Surv; 2008 Nov; 63(11):725-32. PubMed ID: 18928577
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-induced damage to ovary: mechanisms and clinical impact.
Bedoschi G; Navarro PA; Oktay K
Future Oncol; 2016 Oct; 12(20):2333-44. PubMed ID: 27402553
[TBL] [Abstract][Full Text] [Related]
15. Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents.
Roness H; Kalich-Philosoph L; Meirow D
Hum Reprod Update; 2014; 20(5):759-74. PubMed ID: 24833728
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy and fertility.
Blumenfeld Z
Best Pract Res Clin Obstet Gynaecol; 2012 Jun; 26(3):379-90. PubMed ID: 22281514
[TBL] [Abstract][Full Text] [Related]
17. Molecular Mechanism and Prevention Strategy of Chemotherapy- and Radiotherapy-Induced Ovarian Damage.
Kim S; Kim SW; Han SJ; Lee S; Park HT; Song JY; Kim T
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299104
[TBL] [Abstract][Full Text] [Related]
18. Endocrine prevention of chemotherapy-induced ovarian failure.
Blumenfeld Z; Evron A
Curr Opin Obstet Gynecol; 2016 Aug; 28(4):223-9. PubMed ID: 27253235
[TBL] [Abstract][Full Text] [Related]
19. Update on fertility preservation for younger women with breast cancer.
Warner E; Glass K; Foong S; Sandwith E
CMAJ; 2020 Aug; 192(35):E1003-E1009. PubMed ID: 32868272
[No Abstract] [Full Text] [Related]
20. GnRH-analogues for ovarian protection in childhood cancer patients: how adult hypotheses are relevant in prepubertal females.
Osborne SE; Detti L
Curr Drug Targets; 2013 Jul; 14(8):856-63. PubMed ID: 23614679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
